Company News

DSM and Amyris Close Brazilian Business Deal

Author Image

By: TOM BRANNA

Editor

BRAZIL: Royal DSM and Amyris, Inc. have closed the transaction for the sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris’ high-volume products. The accord was first announced in November 2017. 


The consideration for Amyris Brasil Ltda and intellectual property related to farnesene was $58 million plus an additional value share arrangement over a three-year period amounting to $37.5 million, according to DSM.


DSM is continuing existing supply-agreements to Amyris and other parties. DSM will also supply Amyris with specialty compounds until Amyris completes construction of a second facility dedicated to specialty products manufacturing located in Campinas.

Keep Up With Our Content. Subscribe To Happi Newsletters